90555-65-0

Usage

Uses

Used in Organic Synthesis:
3-Ethylphenylboronic acid is used as a reagent for the formation of carbon-carbon bonds, particularly in the Suzuki coupling reaction. It facilitates the efficient and selective formation of complex molecular structures, making it a valuable tool in the synthesis of various organic compounds.
Used in Pharmaceutical Production:
3-Ethylphenylboronic acid is used as a building block in the production of pharmaceuticals. Its ability to form carbon-carbon bonds and its compatibility with various chemical reactions make it suitable for the synthesis of a wide range of drug molecules.
Used in Agrochemical Production:
3-Ethylphenylboronic acid is also used as a building block in the production of agrochemicals. Its versatility in organic synthesis allows for the creation of various agrochemical compounds, contributing to the development of effective and targeted crop protection products.
Used in Electronic Materials Production:
3-Ethylphenylboronic acid is utilized in the production of materials for electronic applications. Its unique properties and reactivity make it suitable for the development of advanced materials used in electronic devices and components.

InChI:InChI=1/C8H11BO2/c1-2-7-4-3-5-8(6-7)9(10)11/h3-6,10-11H,2H2,1H3

Upstream product

• 109-72-8 n-butyllithium 
• 121-43-7 Trimethyl borate 
• 2725-82-8 1-bromo-3-ethylbenzene 
• 108-36-1 1,3-dibromobenzene 

Downstream Products

• 1070870-42-6 2-bromo-4-chloro-3-(3-ethylphenyl)pyridine 
• 725739-67-3 4-(3-ethyl-phenyl)-3,6-dihydro-2H-pyridine-1-sulfonyl chloride 
• 912768-43-5 4-(3-ethyl-phenyl)-1,2,3,6-tetrahydro-pyridine 
• 1185265-44-4 1-[2-(3-ethyl-phenyl)-5H-pyrrolo[2,3-b]pyrazin-7-yl]-2,2-dimethyl-propan-1-one 

Relevant academic research and scientific papers

TRISUBSTITUTED NITROGEN MODULATORS OF TYROSINE PHOSPHATASES

Compounds, compositions and methods are provided for modulating the activity of protein tyrosine phosphatases, including PTP-1B. In one embodiment, the compounds are N,N-dibenzylarylsulfonamides.

Hydroxamic acid derivatives as matrix metalloprotease (MMP) inhibitors

Compounds of formula (I):or pharmaceutically or veterinarily acceptable salts thereof, or pharmaceutically or veterinarily acceptable solvates of either entity, wherein the broken line represents an optional bond; A is C or CH; B is CH2, O or absent; R1 and R2 are each independently selected from hydrogen, C1 to C6 alkyl optionally substituted with C1 to C4 alkoxy or phenyl, and C1 to C6 alkenyl; or, together with the carbon atom to which they are attached, form a C3 to C6 cycloalkyl group which optionally incorporates a heteroatom linkage selected from O, SO, SO2 and NR6 or which is optionally benzo-fused; R3 is hydrogen, halo, R7 or OR7; R4 is hydrogen, C1 to C4 alkyl, C1 to C4 alkoxy, trifluoromethyl or halo; R6 is hydrogen or C1 to C4 alkyl; R7 is an optionally substituted monocyclic or bicyclic ring system; m is 1 or 2; and n is 0, 1 or 2; with the proviso that B is not O when A is C; are MMP inhibitors useful in the treatment of, inter alia, tissue ulceration, wound repair and skin diseases.

Conformational studies by dynamic NMR. 74. Stereomutations of the conformational enantiomers in peri-substituted 1-acylnaphthalenes

Naphthalenes bearing an acyl and a phenyl group in a peri relationship give rise to a pair of enantiomers in the temperature range where the rotations of the acyl group are slow. Such enantiomers were observed by means of low temperature NMR spectra in chiral environments. The barrier to rotation for the acyl substituents, that causes the interconversion of the enantiomers, was demonstrated to be lower than that for the phenyl group. In an appropriately synthesized derivative it was possible to measure the two barriers that were found equal to 10.4 and 15.9 kcal mol-1, respectively. The barriers for the acyl group rotation increase regularly (from 9.5 to 13.2 kcal mol-1) with the increasing dimension of the RCO groups (R = Me, Et, Pr(i), Bu(t)). When a bromine atom replaces the phenyl group, the enantiomerization barrier for the corresponding acyl derivatives increases significantly.